The Oxford Times: Hi-tech pill which will collect samples inside the gut is quite science fiction
A fascinating new Oxford Times article highlights the ground-breaking work of Oxford tech startup, BioMe. imgID69331408.jpg.gallery The BioMe team behind the development of a revolutionary pill (from left) Matthias Thurner, Agnieszka Chomka, Soren Thomsen and Patrick Albers stand in front of the Radcliffe Camera The article highlights how "a hi-tech pill being developed by a team of Oxford scientists could revolutionise the way doctors test for some diseases". Further, "with pills expected to cost £2 each, compared to £800 for an endoscopy session, it could herald a breakthrough for the cash-strapped NHS." BioMe was a former finalist at Venturefest's funding event for investor-ready entrepreneurs, Pitchfest, and has also been shortlisted for The Oxford Trust Enterprise Awards 2016. Read more    

Latest news

Research, industry, and AGI

Research, industry, and AGI

A transfer of knowledge to industry is a good thing:  One purpose of a university is to benefit society by disseminating knowledge, and one way this can be done is by commercialising research. Universities and research institutions are a dynamo for entrepreneurship, and for innovation in large companies. READ MORE

For success in product development – start at square zero

For success in product development – start at square zero

When it comes to the commercial success of a technology-led product, there are a number of factors that come into play along the development journey. Have the regulatory requirements been met? Can the design be produced at a viable cost? Is it possible to ensure the quality of the manufacturing process? The list goes on. READ MORE

The not-so-small matter of scale: Making it big in microfluidics

The not-so-small matter of scale: Making it big in microfluidics

Microfluidics is a key technology enabling the development of rapid in-vitro diagnostics (IVD). With applications including COVID-19 testing, cardiac arrest assessment and STD screening, decentralised rapid diagnostics are shaping up to be a major part of the future of healthcare and wellness monitoring. READ MORE

Keep in touch

Sign up to the Venturefest Oxford newsletter to make sure you are the first to hear the latest news. The next #vfestox newsletter will be coming out soon! Make sure you're on the list!

 

 

 

 

 

Email Preferences

Make connections that lead to new investments, new businesses and new ideas in the high-tech sector in Oxfordshire.